Oligomerization of the Human Immunodeficiency Virus Type 1 (HIV-1) Vpu Protein--a Genetic, Biochemical and Biophysical Analysis

Overview

Journal Virol J

Publisher Biomed Central

Specialty Microbiology

Date 2007 Aug 31

PMID 17727710

Citations 26

Authors

Amjad Hussain

Suman R Das

Charu Tanwar

Shahid Jameel

Affiliations

Soon will be listed here.

Abstract

Background: The human immunodeficiency virus type 1(HIV-1) is a complex retrovirus and the causative agent of acquired immunodeficiency syndrome (AIDS). The HIV-1 Vpu protein is an oligomeric integral membrane protein essential for particle release, viral load and CD4 degradation. In silico models show Vpu to form pentamers with an ion channel activity.

Results: Using Vpu proteins from a primary subtype C and the pNL4-3 subtype B isolates of HIV-1, we show oligomerization of the full-length protein as well as its transmembrane (TM) domain by genetic, biochemical and biophysical methods. We also provide direct evidence of the presence of Vpu pentamers in a stable equilibrium with its monomers in vitro. This was also true for the TM domain of Vpu. Confocal microscopy localized Vpu to the endoplasmic reticulum and Golgi regions of the cell, as well as to post-Golgi vesicles. In fluorescence resonance energy transfer (FRET) experiments in live cells we show that Vpu oligomerizes in what appears to be either the Golgi region or intracellular vesicles, but not in the ER.

Conclusion: We provide here direct evidence that the TM domain, is critical for Vpu oligomerization and the most favourable channel assembly is a pentamer. The Vpu oligomerization appears to be either the Golgi region or intracellular vesicles, but not in the ER.

Citing Articles

Highly versatile small virus-encoded proteins in cellular membranes: A structural perspective on how proteins' inherent conformational plasticity couples with host membranes' properties to control cellular processes.

Saffarian Delkhosh A, Hadadianpour E, Islam M, Georgieva E J Struct Biol X. 2025; 11():100117.

PMID: 39802090 PMC: 11714672. DOI: 10.1016/j.yjsbx.2024.100117.

Differences in Oligomerization of the SARS-CoV-2 Envelope Protein, Poliovirus VP4, and HIV Vpu.

Townsend J, Fapohunda O, Wang Z, Pham H, Taylor M, Kloss B Biochemistry. 2024; 63(3):241-250.

PMID: 38216552 PMC: 10872257. DOI: 10.1021/acs.biochem.3c00437.

HIV-1 Vpu protein forms stable oligomers in aqueous solution via its transmembrane domain self-association.

Majeed S, Dang L, Islam M, Ishola O, Borbat P, Ludtke S Sci Rep. 2023; 13(1):14691.

PMID: 37673923 PMC: 10483038. DOI: 10.1038/s41598-023-41873-0.

Differences in Oligomerization of the SARS-CoV-2 Envelope Protein, Poliovirus VP4, and HIV Vpu.

Townsend J, Fapohunda O, Wang Z, Pham H, Taylor M, Kloss B bioRxiv. 2023; .

PMID: 37645758 PMC: 10462163. DOI: 10.1101/2023.08.18.553902.

HIV-1 Vpu protein forms stable oligomers in aqueous solution via its transmembrane domain self-association.

Majeed S, Dang L, Islam M, Ishola O, Borbat P, Ludtke S bioRxiv. 2023; .

PMID: 37214796 PMC: 10197565. DOI: 10.1101/2023.05.08.539839.

References

Ritter Jr G, Yamshchikov G, Cohen S, Mulligan M . Human immunodeficiency virus type 2 glycoprotein enhancement of particle budding: role of the cytoplasmic domain. J Virol. 1996; 70(4):2669-73. PMC: 190121. DOI: 10.1128/JVI.70.4.2669-2673.1996. View

Strebel K, Klimkait T, Martin M . A novel gene of HIV-1, vpu, and its 16-kilodalton product. Science. 1988; 241(4870):1221-3. DOI: 10.1126/science.3261888. View

Bai C, Sen P, Hofmann K, Ma L, Goebl M, Harper J . SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box. Cell. 1996; 86(2):263-74. DOI: 10.1016/s0092-8674(00)80098-7. View

Bai C, Elledge S . Gene identification using the yeast two-hybrid system. Methods Enzymol. 1996; 273:331-47. DOI: 10.1016/s0076-6879(96)73029-x. View

Ewart G, Sutherland T, Gage P, Cox G . The Vpu protein of human immunodeficiency virus type 1 forms cation-selective ion channels. J Virol. 1996; 70(10):7108-15. PMC: 190763. DOI: 10.1128/JVI.70.10.7108-7115.1996. View

Schubert U, Ferrer-Montiel A, Henklein P, Strebel K, Montal M . Identification of an ion channel activity of the Vpu transmembrane domain and its involvement in the regulation of virus release from HIV-1-infected cells. FEBS Lett. 1996; 398(1):12-8. DOI: 10.1016/s0014-5793(96)01146-5. View

Bour S, Strebel K . The human immunodeficiency virus (HIV) type 2 envelope protein is a functional complement to HIV type 1 Vpu that enhances particle release of heterologous retroviruses. J Virol. 1996; 70(12):8285-300. PMC: 190916. DOI: 10.1128/JVI.70.12.8285-8300.1996. View

Fujita K, Omura S, Silver J . Rapid degradation of CD4 in cells expressing human immunodeficiency virus type 1 Env and Vpu is blocked by proteasome inhibitors. J Gen Virol. 1997; 78 ( Pt 3):619-25. DOI: 10.1099/0022-1317-78-3-619. View

Paul M, Mazumder S, Raja N, Jabbar M . Mutational analysis of the human immunodeficiency virus type 1 Vpu transmembrane domain that promotes the enhanced release of virus-like particles from the plasma membrane of mammalian cells. J Virol. 1998; 72(2):1270-9. PMC: 124605. DOI: 10.1128/JVI.72.2.1270-1279.1998. View

10.

Schubert U, Anton L, Bacik I, Cox J, Bour S, Bennink J . CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway. J Virol. 1998; 72(3):2280-8. PMC: 109526. DOI: 10.1128/JVI.72.3.2280-2288.1998. View

11.

Marassi F, Ma C, Gratkowski H, Straus S, Strebel K, Montal M . Correlation of the structural and functional domains in the membrane protein Vpu from HIV-1. Proc Natl Acad Sci U S A. 1999; 96(25):14336-41. PMC: 24437. DOI: 10.1073/pnas.96.25.14336. View

12.

Hengartner M . The biochemistry of apoptosis. Nature. 2000; 407(6805):770-6. DOI: 10.1038/35037710. View

13.

Bour S, Perrin C, Akari H, Strebel K . The human immunodeficiency virus type 1 Vpu protein inhibits NF-kappa B activation by interfering with beta TrCP-mediated degradation of Ikappa B. J Biol Chem. 2001; 276(19):15920-8. DOI: 10.1074/jbc.M010533200. View

14.

Xia Z, Liu Y . Reliable and global measurement of fluorescence resonance energy transfer using fluorescence microscopes. Biophys J. 2001; 81(4):2395-402. PMC: 1301710. DOI: 10.1016/S0006-3495(01)75886-9. View

15.

Akari H, Bour S, Kao S, Adachi A, Strebel K . The human immunodeficiency virus type 1 accessory protein Vpu induces apoptosis by suppressing the nuclear factor kappaB-dependent expression of antiapoptotic factors. J Exp Med. 2001; 194(9):1299-311. PMC: 2195969. DOI: 10.1084/jem.194.9.1299. View

16.

Siegel R, Chan F, Zacharias D, Swofford R, Holmes K, Tsien R . Measurement of molecular interactions in living cells by fluorescence resonance energy transfer between variants of the green fluorescent protein. Sci STKE. 2001; 2000(38):pl1. DOI: 10.1126/stke.2000.38.pl1. View

17.

Lopez C, Montal M, Blasie J, Klein M, Moore P . Molecular dynamics investigation of membrane-bound bundles of the channel-forming transmembrane domain of viral protein U from the human immunodeficiency virus HIV-1. Biophys J. 2002; 83(3):1259-67. PMC: 1302226. DOI: 10.1016/S0006-3495(02)73898-8. View

18.

Callahan M, Handley M, Lee Y, Talbot K, Harper J, Panganiban A . Functional interaction of human immunodeficiency virus type 1 Vpu and Gag with a novel member of the tetratricopeptide repeat protein family. J Virol. 1998; 72(6):5189-97. PMC: 110095. DOI: 10.1128/JVI.72.6.5189-5197.1998. View

19.

Margottin F, Bour S, Durand H, Selig L, Benichou S, Richard V . A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. Mol Cell. 1998; 1(4):565-74. DOI: 10.1016/s1097-2765(00)80056-8. View

20.

Moore P, Zhong Q, Husslein T, Klein M . Simulation of the HIV-1 Vpu transmembrane domain as a pentameric bundle. FEBS Lett. 1998; 431(2):143-8. DOI: 10.1016/s0014-5793(98)00714-5. View